Real-world safety and implementation challenges of lecanemab therapy for Alzheimer's disease in South Korea: a single-center experience.
- DOI
- 10.1186/s13195-026-02141-1
- Published
- 2026-07-14
- Container
- Alzheimers Res Ther
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13195-026-02141-1,
title = {Real-world safety and implementation challenges of lecanemab therapy for Alzheimer's disease in South Korea: a single-center experience.},
author = {Jang H and Kim JW and Hwang JW and Jeong DW and Ka J and Kang DM and Suh CH and Choi Y and Oh M and Kim JS and Lim JS and Lee JH.},
year = {2026},
journal = {Alzheimers Res Ther},
doi = {10.1186/s13195-026-02141-1},
url = {https://doi.org/10.1186/s13195-026-02141-1}
}RIS
TY - JOUR TI - Real-world safety and implementation challenges of lecanemab therapy for Alzheimer's disease in South Korea: a single-center experience. AU - Jang H AU - Kim JW AU - Hwang JW AU - Jeong DW AU - Ka J AU - Kang DM AU - Suh CH AU - Choi Y AU - Oh M AU - Kim JS AU - Lim JS AU - Lee JH. PY - 2026 JO - Alzheimers Res Ther DO - 10.1186/s13195-026-02141-1 UR - https://doi.org/10.1186/s13195-026-02141-1 ER -
APA
H, J., JW, K., JW, H., DW, J., J, K., DM, K., CH, S., Y, C., M, O., JS, K., JS, L., & JH., L. (2026). Real-world safety and implementation challenges of lecanemab therapy for Alzheimer's disease in South Korea: a single-center experience.. Alzheimers Res Ther. https://doi.org/10.1186/s13195-026-02141-1
Source records
- europe-pmc · retrieved 2026-09-26T05:35:24.464Z